Steroid-Corticosteroids Market Size, Share & Trends Analysis Report By Product (Cream, Injection, Others), By Applications (Hospital, Clinic, Pharmacy, Others), By End Use, By Region, and Segment Forecasts - 2035

STEROID-CORTICOSTEROIDS MARKET OVERVIEW

The global steroid-corticosteroids market size was valued at USD 5093.66 million in 2025 and is projected to grow from USD 5277.03 million in 2026 to USD 5867.71 million by 2035, at a CAGR of 3.6% from 2026 to 2035.

Corticosteroids are steroidal hormones generated in the adrenal cortex and is used to treat various diseases, including renal illness, autoimmune diseases, cerebral edema, skin diseases, and GIT diseases. These steroids are also used in organ transplantation and relief therapy. Factors driving market expansion include an increase in the frequence of chronic and contagious conditions (cancers, respiratory conditions, skin conditions, neurological conditions, and gastrointestinal conditions), an increase in medicine resistance, and reduced product costs. Likewise, the rise in medicinal product use energies the growth of the corticosteroid market. Still, the adverse goods of corticosteroids (similar as cataracts, inordinate blood sugar, weakened bones, and an increased threat of infection) limit market expansion. Continuing R&D enterprise in the pharmaceutical assiduity is expected to give new opportunity for the market throughout the projected period.

The Global market for steroid- corticosteroids has been growing steadily due to the rising number of people with habitual inflammatory conditions and the growing number of aged people. Steroid- corticosteroids are a group of medicines that act like hormones made by the adrenal glands. There are a lot of different companies making and dealing these medicines, so the market is truly competitive and has a lot of different players. Steroid- corticosteroids come in multitudinous forms, analogous as capsules, injections, creams, ointments, and inhalers. They treat various conditions, analogous as respiratory conditions, skin conditions, and common pain.

• • 

    Download Free sample to learn more about this report.

KEY FINDINGS

• Market Size and Growth: The Steroid-Corticosteroids Market size was USD 4916.65 Million in 2024, is projected to grow to USD 5085 Million by 2025 and exceed USD 5467 Million by 2033, with a CAGR of 3.6%.

• Key Market Driver: Increasing prevalence of chronic respiratory diseases like asthma, which affects over 260 million people globally, is pushing demand for corticosteroid-based treatments.

• Major Market Restraint: Concerns about long-term side effects, including osteoporosis and weight gain, limit prolonged usage; around 20% of patients discontinue therapy due to adverse effects.

• Emerging Trends: The shift towards inhaled corticosteroids is gaining traction, with usage in combination therapies rising by nearly 15% in the last two years.

• Regional Leadership: North America leads the market, contributing approximately 40% of global consumption, thanks to advanced healthcare infrastructure and high prescription rates.

• Competitive Landscape: The sector is moderately consolidated, with about 10 major pharmaceutical players, including Pfizer and GlaxoSmithKline, driving most innovations and supply.

• Market Segmentation: Oral corticosteroids dominate, accounting for close to 50% of total usage, largely due to their effectiveness in managing severe inflammatory conditions.

• Recent Development: In 2023, several biotech firms launched novel formulations with reduced side-effect profiles, cutting adverse reaction rates by roughly 25% in clinical trials.

COVID-19 IMPACT

"Steroid-corticosteroids Industry had a positive Effect Due to Increased Demand during COVID-19 Pandemic"

The Global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

The COVID- 19 epidemic significantly impacted the steroid- corticosteroids market, leading to increased demand for corticosteroids in treating severe cases. Medicines like dexamethasone gained elevation for their effectiveness in managing inflammation and respiratory complications in COVID- 19 cases. Still, force chain dislocations and heightened nonsupervisory scrutiny created challenges for manufacturers. As telehealth became more current, mindfulness of steroid treatments for habitual conditions also grew, reshaping patient engagement and healthcare practices moving forward.

LATEST TREND

"Rise of Biologics and Personalized Medicine to Drive Market Growth"

Recent traits inside the steroid-corticosteroids industry include rise of biologics and personalized medicine approaches. As healthcare shifts toward acclimatized treatments, birth curatives are gaining traction for their capability to target specific pathways in seditious and autoimmune conditions. These alternatives promise smaller side goods and further effective issues, prompting cases and healthcare providers to seek options beyond traditional corticosteroids. This trend not only reflects advances in medical wisdom but also signals a potentials transformation in chronic diseases operation strategies.

• • 

    Download Free sample to learn more about this report.

STEROID-CORTICOSTEROIDS MARKET SEGMENTATION

By Type

Based on Type, the global market can be categorized into Cream, Injection and Other

• Cream: Corticosteroid creams are made to be put on the skin directly. They are used to treat eczema, psoriasis, dermatitis, and antipathetic responses, among other skin problems. Most of the time, creams are stylish for rashes or vexations only in one spot.

• Injection: Corticosteroid injections involve putting the medicine straight into a certain body part, similar as a joint, muscle, or tendon. With these injections, a bigger attention of the medicine is transferred to the area of pain or inflammation. This makes pain and inflammation go down snappily and in a specific area.

• Others: Other types of steroid- corticosteroids include hydrocortisone, prednisone, methylprednisolone, and betamethasone, each varying in energy and operations for conditions like inflammation, disinclinations, and autoimmune diseases.

By Application

Based on Application, the global market can be categorized into Hospital, Clinic and Others

• Hospital: Hospitals use corticosteroid drugs to treat conditions analogous as severe asthma flare- ups, acute antipathetic responses, autoimmune conditions, and inflammation after surgery. In hospitals, corticosteroids can be given in different ways, analogous as by intravenous (IV) injection, intramuscular (IM) injection, or as part of inhalation treatment.

• Clinic: Outpatient centres are where steroid- corticosteroids are given. Conventions treat various health problems, similar as chronic conditions, skin, musculoskeletal, and respiratory ails. Based on the condition and treatment needs, corticosteroids can be given in these situations through creams, tablets, injections, or inhalation therapy.
• Others: Steroid- corticosteroids are applied in treating various conditions, including disinclinations, asthma, autoimmune conditions, skin diseases, and seditious conditions. They help reduce inflammation, suppress vulnerable responses, and manage pain effectively.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.

DRIVING FACTORS

"Growing Demand for Topical Corticosteroids to boost the Market"

A factor in the Steroid-Corticosteroids Market growth is the growing demand for topical corticosteroids. Dermatologists constantly define topical corticosteroids to manage various skin diseases, including eczema, psoriasis, and dermatitis. These specifics help reduce inflammation, itchiness, and redness, furnishing relief to cases affected by these increasingly current skin issues. The rising prevalence of similar conditions has led to a higher demand for effective treatments, making topical corticosteroids essential in dermatological practice. As mindfulness grows regarding skin health, the focus on accessible and effective remedies further drives the market for these topical treatments.

"Increasing Advancements in Drugs Delivery Systems to Drive Market Growth"

The Increasing advancement in drugs delivery systems are another key aspect of the Steroid-Corticosteroids Market. New Medicine delivery systems, including inhalers and nasal drops, have significantly simplified the administration of corticosteroids, enhancing patient adherence to treatment rules. These innovative styles insure accurate dosing and ameliorate availability, making it easier for cases to use the products effectively. As a result, the market for corticosteroids is passing rapid growth, driven by the convenience of these delivery systems. With adding mindfulness around respiratory and antipathetic conditions, the demand for user-friendly phrasings is anticipated to continue rising.

Restraining Factor

"Emerging Alternative Treatment Method"" to Potentially Impede Market Growth"

The Emerging alternative treatment method poses a significant restraining factor for the growth of the Steroid-Corticosteroids Market. Scientists and pharmaceutical companies are continuously exploring innovative approaches to diseases treatment, including focused natural curatives, gene remedy, and regenerative drug. These advancements aim to give further effective and safer alternatives for managing various conditions. As these new curatives gain traction, they've the eventuality to reduce reliance on traditional remedies, similar as steroid corticosteroids. This shift could lead to better case issues while minimizing the side goods frequently associated with long- term corticosteroid use, reshaping the geography of treatment options.

OPPORTUNITY

"Expansion in Emerging Market to Create Opportunity for the Product in the Market"

An opportunity in the steroid- corticosteroids market lies in the expansion into arising markets, where rising middle- class populations and increased healthcare access are driving demand for effective treatments. As mindfulness of habitual conditions like asthma, eczema, and autoimmune conditions grows, the need for corticosteroid curatives is likely to increase. Pharmaceutical companies can subsidize on this trend by developing affordable, accessible products provisioned to these regions while navigating original regulations and erecting partnership with healthcare providers to enhance distribution.

CHALLENGE

"Growing Concerns over Side Effects Could Be a Potential Challenge for Consumers"

One of the significant challenges in the steroid- corticosteroids market is growing enterprises over the implicit side goods associated with long- term use, similar as skin thinning, hormonal imbalances, and increased vulnerability to infections. These enterprises have led to heightened scrutiny from healthcare providers and cases likewise, driving demand for safer alternatives. As a result, pharmaceutical companies must concentrate on developing phrasings that minimize adverse goods while maintaining efficacy, which can complicate exploration and development processes and increase costs.

• • 

    Download Free sampleto learn more about this report.

•  

STEROID-CORTICOSTEROIDS MARKET REGIONAL INSIGHTS

NORTH AMERICA

The Region dominates the Steroid-Corticosteroids Market share. It has a well- developed healthcare system and a high frequency of chronic conditions, contributing to the market's growth. Canada and Mexico also contribute to the North American market. The United States places a significant emphasis on exploration and development, introducing advanced corticosteroid phrasings and treatment approaches. The region has a high frequency of chronic conditions like asthma, arthritis, and seditious bowel diseases, performing in high demand for corticosteroid specifics. In this region, an established healthcare structure, advanced exploration installations, and robust nonsupervisory fabrics contribute to market growth.

EUROPE

Europe's major steroid- corticosteroid markets are Germany, the United Kingdom, France, Italy, Russia, and Spain. These nations have well- established healthcare systems, sophisticated medical exploration capacities, and high healthcare expenditures. The region suffers from a high frequency of chronic conditions, especially respiratory conditions, and autoimmune diseases, performing in a significant demand for corticosteroid curatives. The European market is subject to strict nonsupervisory conditions to insure patient safety and the chastity of specifics.

ASIA

The Asia- Pacific region, which includes China, Japan, South Korea, India, Australia, and Southeast Asian countries, is a large market for steroid- corticosteroids. A large population, accelerated urbanization, and a growing frequency of chronic conditions characterize the region. This region's market is growing due to growing healthcare structure, bettered access to healthcare, and increased mindfulness of the benefits of corticosteroid curatives.

KEY INDUSTRY PLAYERS

"Key Industry Players Shaping the Market through Innovation and Market Expansion"

Key enterprise players are shaping the Steroid-Corticosteroids Marketplace through strategic innovation and marketplace growth. These agencies are introducing superior milling strategies to beautify the fine and nutritional profile. They are also increasing their product traces to include specialized versions like organic and vertical farming, catering to various purchaser preferences. Additionally, they may be leveraging virtual systems for greater market reach and distribution performance. By making an investment in research and improvement, improving delivery chain managements, and exploring new regional markets, those players are riding a boom and setting traits within the steroid-corticosteroids enterprise.

LIST OF TOP STEROID-CORTICOSTEROIDS COMPANIES

• Sumitomo( Japan)
• Pfizer (U.S.)
• Novartis (Switzerland)
• Merck (U.S.)
• Sanofi (France)
• Johnson and Johnson (U.S.)
• GSK (U.K.)
• AstraZeneca (U.S.)
• Cipla (India)

KEY INDUSTRIAL DEVELOPMENT

June 2024 - Sumitomo Chemical Co., Ltd. (""""Sumitomo Chemical"""") and REVER CORPORATION (""""REVER"""") have made a deal to work together on recycling waste plastics from vehicles that have reached the end of their useful lives (ELVs). Through this partnership, the two companies will work to build a circular system for recycling waste plastics that includes the whole process, from collecting to sorting to recycling into useful plastic resources. They will also work to speed up business development for plastic recycling, which has become an important issue in the auto industry and society as a whole.

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

The research report delves into market segmentation, utilizing both qualitative and quantitative research methods to provide a thorough analysis. It also evaluates the impact of financial and strategic perspectives on the market. Furthermore, the report presents national and regional assessments, considering the dominant forces of supply and demand that influence market growth. The competitive landscape is meticulously detailed, including market shares of significant competitors. The report incorporates novel research methodologies and player strategies tailored for the anticipated timeframe. Overall, it offers valuable and comprehensive insights into the market dynamics in a formal and easily understandable manner.